Live-cell imaging could open new frontiers in cancer drug discovery: Experts
The convergence of photonics, AI, microfluidics and live-cell analytics could offer researchers a new way to study disease biology, not merely as a series of static snapshots, but as processes unfolding in real time

One Ant Sparks Colony-Wide Burst: Math Cracks 30-Year Mystery of Ant Synchronization
Ant colony synchronization has been explained for the first time by NYU and NJIT engineers, who found that a single ant can trigger a colony-wide burst of activity via a phase transition -- the same physics that governs magnets and ice. Published August 5, 2026, the study has direct implications for swarm robotics design and complex systems biology.

Depression Linked to Shrinking Brain Region in Older Adults
The memory center of the brain show signs of decreasing volume The post Depression Linked to Shrinking Brain Region in Older Adults appeared first on Nautilus .

Recursion Pharmaceuticals (NASDAQ:RXRX) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS
Recursion Pharmaceuticals (NASDAQ:RXRX – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.25) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.01), FiscalAI reports. The firm had revenue of $7.67 million for the quarter, compared to analysts’ expectations of $10.97 million. Recursion Pharmaceuticals had a [...]

Early Stress Heightens Adult Anxiety
Early-life stress elevates the enzyme SETD7 in dopamine neurons, uncoiling DNA and creating a physical scar that heightens adult stress vulnerability.

Sadler Gibb leads in new SEC audit clients in Q2
Meanwhile, KPMG and Grant Thornton led in terms of new engagements among the largest audit firms.

Show Me The Money: After An 800%+ Gain, PRAX Enters A High-Stakes Stretch
With four late-stage assets, three FDA Breakthrough Therapy Designations, and two upcoming PDUFA decisions, Praxis Precision Medicines (PRAX), a CNS precision neuroscience biopharmaceutical company, is entering a defining chapter.

Show Me The Money: After An 800%+ Gain, PRAX Enters A High-Stakes Stretch
(RTTNews) - With four late-stage assets, three FDA Breakthrough Therapy Designations, and two upcoming PDUFA decisions, Praxis Precision Medicines (PRAX), a CNS precision neuroscience biopharmaceutical company, is entering a defining chapter. The two drug candidates under FDA review are <b>Ulixacaltamide</b> and <b>Relutrigine</b>.

How Overconfidence and Loss Aversion Co-Evolved
A new study demonstrates that human overconfidence persists because its decision-making costs make it a credible, peacock-like evolutionary signal of underlying ability.

U of T Ranks 4th Globally, 2nd Among Publics: NTU
The University of Toronto is ranked fourth in the world - and second among public universities - in the latest NTU World University Rankings .U of T
